Connect with us
Oryzon plans to maintain its share capital at €3.03 million and seek admission for new shares on Madrid, Barcelona, Bilbao, and Valencia Stock Exchanges. The biopharmaceutical...
ALA Diagnostics secured €1.1 million in a financing round in June, supporting its activities in the general laboratory, including Elisa tests. The company also focuses on...
In 2022, the laboratory closed the financial year with a turnover of more than €272 million, an increase of 15.7% compared to 2021. In Spain, the...
In short, the watch launched by Durcal acts as a solution for elderly people who live alone and are not considering moving to a residence. In...
Both projects started on April 1st, 2023, and are expected to last approximately two years. The biopharmaceutical company reduced its losses by 56% in the first...
Microviable Therapeutics emerged as a spin-off of Ipla-Csic in 2016, focused on the development of therapeutic technologies and products derived from microbiota. Technological development, together with the...
Marsi Bionics aims to invest the capital raised in the round in financing the company's international expansion, accessing new markets, and in the industrialization of production...
Grifols is a publicly traded Catalan pharmaceutical company. The company's activity is focused on the research, development, manufacturing, and marketing of plasma-derived products (blood products), intravenous...
ALA Diagnostics closed its first round of financing in 2021 for the development of the Em Kit, the first test for the early diagnosis of Multiple...
In 2022, the company's results stood at €15.6 million, which translates into a rise of 47.2% compared to the previous year. However, in the same period,...